Dana-Farber Cancer Institute is launching a year-long celebration of its 75th anniversary to highlight its history and progress in cancer care and transformative cancer research.
Dana-Farber Cancer Institute is launching a year-long celebration of its 75th anniversary to highlight its history and progress in cancer care and transformative cancer research. In marking the notable anniversary, Dana-Farber seeks to recognize the Institute’s many scientific discoveries, advancements in cancer care for patients, and its extraordinary contributions to eradicating cancer in both children and adults.
“From the first remissions with chemotherapy in 1947 to the most recent new immunotherapies, Dana-Farber has helped push progress against cancer for patients, everywhere,” said Dana-Farber President and CEO, Laurie H. Glimcher, MD. “We celebrate the rich history this anniversary represents, even as we rededicate ourselves to relieve the burden of cancer in the years ahead.”
Dana-Farber will celebrate the milestone anniversary throughout 2022 with signage around the Longwood Medical Area, a dedicated web hub, social media content featuring historical moments in Dana-Farber history, a workforce celebration, and other events to be announced throughout the year. Other historical initiatives, include a Voices of History video project to capture thoughts and memories from key figures from Dana-Farber’s history.
Boston Mayor Michelle Wu will also issue a City of Boston Proclamation today, announcing March 30, 2022 as Dana-Farber Cancer Institute Day.
“Our work over many decades has been marked by an incredible community of scientists, clinicians, nurses, staff and volunteers, all working together with our patients and families for the best possible outcome today and tomorrow,” said Josh Bekenstein, chairman of the Board of Trustees. “We are grateful for their efforts and dedication to the mission we all share.”
In 1947, Sidney Farber, MD, founded the Children's Cancer Research Foundation, dedicated to providing compassionate, state-of-the-art treatment to children with cancer while developing the cancer preventatives, treatments, and cures of the future.
The foundation officially expanded its programs to include patients of all ages in 1969, and in 1974 became known as the Sidney Farber Cancer Center in honor of its founder. The long-term support of the Charles A. Dana Foundation was acknowledged by incorporating the Institute under its present name in 1983.
Throughout its history, Dana-Farber researchers and physicians have contributed numerous scientific breakthrough in both the understanding of cancer biology and the treatment of the disease across all types of cancer including:
Over the last decade, Dana-Farber researchers have helped to usher in a new era in personalized cancer treatment using precision medicine, targeted treatments and becoming a world leader in leveraging the human immune system to fight cancer. Advancements have included:
Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School, a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center, a federally designated comprehensive cancer center. Dana-Farber also maintains affiliations with several schools of nursing in the Boston area.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the generous support of numerous foundations and individuals who contribute to the Institute's individual research and clinic programs or to the Jimmy Fund, the principal charity of the Institute, named for one of its child patients.
For more information on Dana-Farber’s 75th anniversary, visit www.dana-farber.org/75